Browsing Tag

New Test

Corewell Health System, Hematology

Schistocyte Review Test Now Available to Order

Effective Wednesday, April 29, 2026, Schistocyte Review (LAB1231565) will be available to order across all Corewell Health Laboratories Hematology Departments.

This new orderable supports alignment across Corewell Health regions by standardizing schistocyte assessment practices, ensuring high‑quality testing, and delivering a consistent patient care experience system‑wide.

Continue Reading

Advanced Technology Laboratory

New Test Available: Myxoid Liposarcoma Panel by FISH

We are pleased to announce the launch of the Myxoid Liposarcoma Panel by Fluorescence in situ Hybridization (FISH), now available for clinical ordering on Formalin-fixed, paraffin-embedded (FFPE) tissue.

The Myxoid Liposarcoma Panel by FISH includes:

  • CHOP (DDIT3) (12q13) Rearrangement
  • FUS (16p11) Rearrangement

These probes may also be ordered individually.


Test Ordering Information


Questions? We’re Here to Help

For additional clinical details or follow-up questions regarding this test, please use the contact us link above.

Southwest Michigan, West Michigan

Testosterone Testing and Ordering Recommendations

Effective March 4, 2026, Corewell Health Laboratories in West Michigan will discontinue performing testosterone testing (LAB173 and LAB2111222) and Corewell Health Southwest Michigan will discontinue Testosterone Free and Total testing (LAB173)

The following replacements will be available as a send out to Quest Diagnostics:

Testosterone, Total, MS – Epic Code: LAB1232313

Testosterone, Free, Bioavailable and Total, MS – Epic Code: LAB1232237 Continue Reading

Corewell Health System, Emergency, Inpatient

New Test: Antiphospholipid Antibody Panel (Inpatient and Emergency Department)

Effective March 4, 2026, an Antiphospholipid Antibody Panel will be available for adult patients in the emergency, observation, and inpatient settings across the Corewell Health System.

This update is intended to streamline the ordering of appropriate hypercoagulation and thrombophilia testing in alignment with current evidence‑based best practices.

Continue Reading

Referral/Sendouts

Send Out Referral Testing Update: Phase Two Transition to Quest Diagnostics

Go-Live Date: December 17, 2025

Following Phase One in November, where tests previously referred to ARUP and some Mayo Clinic Lab tests were transitioned to Quest Diagnostics, we are now moving into Phase Two of this important change. Corewell Health Laboratory is continuing its transition to Quest Diagnostics as our primary reference testing partner.

Continue Reading